Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
The dedicated HPB and liver transplant centre will be headed by Dr. Vivek Vij, Chairman -Advanced Surgical GI, HPB & Liver Transplant and his team of experts
The company has reported total income of Rs.3031 crores during the calendar year ended December 31, 2021.
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
Data from the Phase 2b QUASAR Induction Study showed approximately 60% of patients achieved the primary endpoint of clinical response, and approximately 30% showed endoscopic improvement with TREMFYA treatment compared with placebo
The company registered consolidated total revenue of Rs 590.70 crore for Q3FY22.
The insights collected by the app will support the pharmaceutical industry’s efforts to further improve patients’ lives by providing actionable data on patients’ individual experiences
Evonik invests in start-up to improve patient recovery after open-chest surgery
The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
